In the story "GlaxoSmithKline Cuts Staff in China Amid Probe -- Update," which ran at 7:48 a.m. EDT, incorrectly stated the period for the company's China sales.

The company's China sales in 2012, not the fourth quarter, rose 17% to GDP759 million, or $1.26 billion at current exchange rates, up from a year earlier.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

GSK (NYSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more GSK Charts.
GSK (NYSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more GSK Charts.